Daiwa Securities Group’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-91
| Closed | -$28K | – | 1482 |
|
|
2025
Q4 | $28K | Sell |
91
-15
| -14% | -$4.91K | ﹤0.01% | 1146 |
|
|
2025
Q3 | $36K | Sell |
106
-39
| -27% | -$11.8K | ﹤0.01% | 1112 |
|
|
2025
Q2 | $35K | Buy |
145
+6
| +4% | +$1.47K | ﹤0.01% | 1081 |
|
|
2025
Q1 | $38K | Sell |
139
-7
| -5% | -$1.64K | ﹤0.01% | 1039 |
|
|
2024
Q4 | $27K | Sell |
146
-12
| -8% | -$2.45K | ﹤0.01% | 1080 |
|
|
2024
Q3 | $35K | Hold |
158
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q2 | $23K | Hold |
158
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q1 | $25K | Sell |
158
-14
| -8% | -$2.25K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $31K | Sell |
172
-1,157
| -87% | -$209K | ﹤0.01% | 1102 |
|
|
2023
Q3 | $239K | Buy |
1,329
+452
| +52% | +$89.4K | ﹤0.01% | 931 |
|
|
2023
Q2 | $157K | Buy |
877
+710
| +425% | +$164K | ﹤0.01% | 964 |
|
|
2023
Q1 | $36K | Sell |
167
-25
| -13% | -$6K | ﹤0.01% | 1059 |
|
|
2022
Q4 | $42K | Buy |
192
+9
| +5% | +$1.65K | ﹤0.01% | 1055 |
|
|
2022
Q3 | $25K | Hold |
183
| – | – | ﹤0.01% | 1094 |
|
|
2022
Q2 | $30K | Buy |
183
+38
| +26% | +$5.94K | ﹤0.01% | 1105 |
|
|
2022
Q1 | $27K | Sell |
145
-2,076
| -93% | -$441K | ﹤0.01% | 1103 |
|
|
2021
Q4 | $601K | Buy |
2,221
+1,127
| +103% | +$381K | ﹤0.01% | 824 |
|
|
2021
Q3 | $397K | Sell |
1,094
-81
| -7% | -$26.5K | ﹤0.01% | 887 |
|
|
2021
Q2 | $403K | Buy |
1,175
+134
| +13% | +$44.4K | ﹤0.01% | 867 |
|
|
2021
Q1 | $362K | Buy |
1,041
+952
| +1,070% | +$315K | ﹤0.01% | 865 |
|
|
2020
Q4 | $23K | Sell |
89
-1,952
| -96% | -$537K | ﹤0.01% | 972 |
|
|
2020
Q3 | $585K | Buy |
2,041
+207
| +11% | +$48.7K | 0.01% | 652 |
|
|
2020
Q2 | $226K | Hold |
1,834
| – | – | ﹤0.01% | 745 |
|
|
2020
Q1 | $226K | Sell |
1,834
-294
| -14% | -$46K | ﹤0.01% | 837 |
|
|
2019
Q4 | $353K | Sell |
2,128
-29
| -1% | -$4.82K | ﹤0.01% | 804 |
|
|
2019
Q3 | $264K | Buy |
2,157
+110
| +5% | +$14.6K | ﹤0.01% | 817 |
|
|
2019
Q2 | $254K | Hold |
2,047
| – | – | ﹤0.01% | 836 |
|
|
2019
Q1 | $270K | Sell |
2,047
-8
| -0.4% | -$1.08K | ﹤0.01% | 802 |
|
|
2018
Q4 | $288K | Buy |
2,055
+1,860
| +954% | +$247K | ﹤0.01% | 748 |
|
|
2018
Q3 | $34K | Hold |
195
| – | – | ﹤0.01% | 980 |
|
|
2018
Q2 | $30K | Sell |
195
-5,414
| -97% | -$966K | ﹤0.01% | 995 |
|
|
2018
Q1 | $942K | Buy |
+5,609
| New | +$760K | 0.01% | 506 |
|
Other funds holding ONC
BBA
HA
Daiwa Securities Group's ONC Position: Q1 2026 in Review
Daiwa Securities Group sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 91 shares — an estimated $28K sold.
Daiwa Securities Group first reported a position in ONC in Q1 2018 and held it in 32 quarters. The position peaked at $942K in Q1 2018. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Daiwa Securities Group reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 91 BeOne Medicines Ltd shares in Q1 2026, an estimated $28K.
- Daiwa Securities Group first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's BeOne Medicines Ltd position peaked at $942K in Q1 2018.
- 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.